nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfasalazine—ankylosing spondylitis—psoriasis	0.239	0.526	CtDrD
Sulfasalazine—rheumatoid arthritis—psoriasis	0.216	0.474	CtDrD
Sulfasalazine—PPARG—psoriasis	0.185	1	CbGaD
Sulfasalazine—PLA2G1B—Betamethasone—psoriasis	0.0771	0.271	CbGbCtD
Sulfasalazine—PLA2G1B—Dexamethasone—psoriasis	0.0449	0.158	CbGbCtD
Sulfasalazine—SLC46A1—Methotrexate—psoriasis	0.0361	0.127	CbGbCtD
Sulfasalazine—CYP3A5—Beclomethasone—psoriasis	0.0119	0.0418	CbGbCtD
Sulfasalazine—SLCO1B1—Mycophenolate mofetil—psoriasis	0.0107	0.0378	CbGbCtD
Sulfasalazine—ABCC2—Mycophenolate mofetil—psoriasis	0.00943	0.0332	CbGbCtD
Sulfasalazine—PTGS2—Triamcinolone—psoriasis	0.00932	0.0328	CbGbCtD
Sulfasalazine—ABCG2—Mycophenolate mofetil—psoriasis	0.00853	0.03	CbGbCtD
Sulfasalazine—SLCO1B1—Cyclosporine—psoriasis	0.00813	0.0286	CbGbCtD
Sulfasalazine—PTGS2—Betamethasone—psoriasis	0.008	0.0281	CbGbCtD
Sulfasalazine—ABCC2—Cyclosporine—psoriasis	0.00715	0.0252	CbGbCtD
Sulfasalazine—ABCG2—Hydrocortisone—psoriasis	0.00684	0.0241	CbGbCtD
Sulfasalazine—ABCG2—Cyclosporine—psoriasis	0.00646	0.0227	CbGbCtD
Sulfasalazine—TBXAS1—skeletal joint—psoriasis	0.00638	0.329	CbGeAlD
Sulfasalazine—CYP3A5—Mycophenolate mofetil—psoriasis	0.00472	0.0166	CbGbCtD
Sulfasalazine—ABCC2—Dexamethasone—psoriasis	0.00471	0.0166	CbGbCtD
Sulfasalazine—PTGS2—Dexamethasone—psoriasis	0.00465	0.0164	CbGbCtD
Sulfasalazine—SLCO1B1—Methotrexate—psoriasis	0.0043	0.0152	CbGbCtD
Sulfasalazine—ABCG2—Dexamethasone—psoriasis	0.00426	0.015	CbGbCtD
Sulfasalazine—CYP3A5—Hydrocortisone—psoriasis	0.00379	0.0133	CbGbCtD
Sulfasalazine—ABCC2—Methotrexate—psoriasis	0.00378	0.0133	CbGbCtD
Sulfasalazine—CYP3A5—Cyclosporine—psoriasis	0.00358	0.0126	CbGbCtD
Sulfasalazine—ABCG2—Methotrexate—psoriasis	0.00342	0.012	CbGbCtD
Sulfasalazine—PPARG—dermis—psoriasis	0.00278	0.144	CbGeAlD
Sulfasalazine—CYP3A5—Dexamethasone—psoriasis	0.00236	0.0083	CbGbCtD
Sulfasalazine—PTGS2—skeletal joint—psoriasis	0.00123	0.0634	CbGeAlD
Sulfasalazine—Olsalazine—IFNG—psoriasis	0.000983	0.494	CrCbGaD
Sulfasalazine—PTGS2—synovial membrane of synovial joint—psoriasis	0.000933	0.0482	CbGeAlD
Sulfasalazine—ACAT1—tendon—psoriasis	0.000877	0.0453	CbGeAlD
Sulfasalazine—CHUK—skin of body—psoriasis	0.000858	0.0443	CbGeAlD
Sulfasalazine—PPARG—endothelium—psoriasis	0.00085	0.0439	CbGeAlD
Sulfasalazine—TBXAS1—tendon—psoriasis	0.000733	0.0378	CbGeAlD
Sulfasalazine—SLC46A1—tendon—psoriasis	0.000653	0.0337	CbGeAlD
Sulfasalazine—PTGS2—skin epidermis—psoriasis	0.000599	0.0309	CbGeAlD
Sulfasalazine—IKBKB—skin of body—psoriasis	0.000583	0.0301	CbGeAlD
Sulfasalazine—Balsalazide—PPARG—psoriasis	0.000545	0.274	CrCbGaD
Sulfasalazine—Olsalazine—PPARG—psoriasis	0.000463	0.233	CrCbGaD
Sulfasalazine—PTGS1—endothelium—psoriasis	0.000454	0.0235	CbGeAlD
Sulfasalazine—IKBKB—tendon—psoriasis	0.000444	0.0229	CbGeAlD
Sulfasalazine—PTGS2—endothelium—psoriasis	0.000434	0.0224	CbGeAlD
Sulfasalazine—PPARG—skin of body—psoriasis	0.000363	0.0187	CbGeAlD
Sulfasalazine—PPARG—tendon—psoriasis	0.000276	0.0143	CbGeAlD
Sulfasalazine—ABCC2—tendon—psoriasis	0.000243	0.0125	CbGeAlD
Sulfasalazine—PTGS1—skin of body—psoriasis	0.000194	0.01	CbGeAlD
Sulfasalazine—PTGS2—skin of body—psoriasis	0.000185	0.00958	CbGeAlD
Sulfasalazine—PTGS1—tendon—psoriasis	0.000148	0.00763	CbGeAlD
Sulfasalazine—PTGS2—tendon—psoriasis	0.000141	0.00729	CbGeAlD
Sulfasalazine—PTGS2—Fluocinonide—Clobetasol propionate—psoriasis	0.000133	0.068	CbGdCrCtD
Sulfasalazine—SLC7A11—Dexamethasone—Clobetasol propionate—psoriasis	0.000108	0.0549	CbGdCrCtD
Sulfasalazine—SLC7A11—Betamethasone—Clobetasol propionate—psoriasis	0.000108	0.0549	CbGdCrCtD
Sulfasalazine—PTGS2—Fluocinonide—Beclomethasone—psoriasis	0.000107	0.0545	CbGdCrCtD
Sulfasalazine—PTGS2—Fluocinonide—Fluocinolone Acetonide—psoriasis	0.000104	0.0529	CbGdCrCtD
Sulfasalazine—SLC7A11—Dexamethasone—Beclomethasone—psoriasis	8.62e-05	0.044	CbGdCrCtD
Sulfasalazine—SLC7A11—Betamethasone—Fluocinonide—psoriasis	8.62e-05	0.044	CbGdCrCtD
Sulfasalazine—SLC7A11—Betamethasone—Beclomethasone—psoriasis	8.62e-05	0.044	CbGdCrCtD
Sulfasalazine—SLC7A11—Dexamethasone—Fluocinonide—psoriasis	8.62e-05	0.044	CbGdCrCtD
Sulfasalazine—SLC7A11—Dexamethasone—Fluocinolone Acetonide—psoriasis	8.38e-05	0.0428	CbGdCrCtD
Sulfasalazine—SLC7A11—Betamethasone—Fluocinolone Acetonide—psoriasis	8.38e-05	0.0428	CbGdCrCtD
Sulfasalazine—PTGS2—Fluticasone Propionate—Clobetasol propionate—psoriasis	8.04e-05	0.041	CbGdCrCtD
Sulfasalazine—PTGS2—Fluticasone Propionate—Fluocinonide—psoriasis	6.44e-05	0.0329	CbGdCrCtD
Sulfasalazine—PTGS2—Fluticasone Propionate—Beclomethasone—psoriasis	6.44e-05	0.0329	CbGdCrCtD
Sulfasalazine—PTGS2—Fluticasone Propionate—Fluocinolone Acetonide—psoriasis	6.26e-05	0.0319	CbGdCrCtD
Sulfasalazine—PTGS2—Fluocinonide—Dexamethasone—psoriasis	4.86e-05	0.0248	CbGdCrCtD
Sulfasalazine—PTGS2—Fluocinonide—Betamethasone—psoriasis	4.86e-05	0.0248	CbGdCrCtD
Sulfasalazine—PTGS2—Fluocinonide—Triamcinolone—psoriasis	4.75e-05	0.0243	CbGdCrCtD
Sulfasalazine—SLC7A11—Dexamethasone—Hydrocortisone—psoriasis	4.23e-05	0.0216	CbGdCrCtD
Sulfasalazine—SLC7A11—Betamethasone—Hydrocortisone—psoriasis	4.23e-05	0.0216	CbGdCrCtD
Sulfasalazine—SLC7A11—Dexamethasone—Betamethasone—psoriasis	3.93e-05	0.0201	CbGdCrCtD
Sulfasalazine—SLC7A11—Betamethasone—Dexamethasone—psoriasis	3.93e-05	0.0201	CbGdCrCtD
Sulfasalazine—SLC7A11—Betamethasone—Triamcinolone—psoriasis	3.84e-05	0.0196	CbGdCrCtD
Sulfasalazine—SLC7A11—Dexamethasone—Triamcinolone—psoriasis	3.84e-05	0.0196	CbGdCrCtD
Sulfasalazine—SLC7A11—Dexamethasone—Prednisone—psoriasis	3.64e-05	0.0186	CbGdCrCtD
Sulfasalazine—SLC7A11—Betamethasone—Prednisone—psoriasis	3.64e-05	0.0186	CbGdCrCtD
Sulfasalazine—SLC7A11—Betamethasone—Prednisolone—psoriasis	3.56e-05	0.0181	CbGdCrCtD
Sulfasalazine—SLC7A11—Dexamethasone—Prednisolone—psoriasis	3.56e-05	0.0181	CbGdCrCtD
Sulfasalazine—PTGS2—Fluticasone Propionate—Betamethasone—psoriasis	2.93e-05	0.015	CbGdCrCtD
Sulfasalazine—PTGS2—Fluticasone Propionate—Dexamethasone—psoriasis	2.93e-05	0.015	CbGdCrCtD
Sulfasalazine—PTGS2—Fluticasone Propionate—Triamcinolone—psoriasis	2.87e-05	0.0146	CbGdCrCtD
Sulfasalazine—PLA2G1B—Metabolism—CAT—psoriasis	1.52e-05	0.000288	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—TAGAP—psoriasis	1.52e-05	0.000287	CbGpPWpGaD
Sulfasalazine—PTGS2—Spinal Cord Injury—CXCL8—psoriasis	1.51e-05	0.000287	CbGpPWpGaD
Sulfasalazine—IKBKB—Fc epsilon receptor (FCERI) signaling—NFKB1—psoriasis	1.5e-05	0.000284	CbGpPWpGaD
Sulfasalazine—IKBKB—MyD88-independent cascade—IL6—psoriasis	1.5e-05	0.000284	CbGpPWpGaD
Sulfasalazine—CHUK—Activated TLR4 signalling—IL6—psoriasis	1.49e-05	0.000282	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by FGFR in disease—STAT3—psoriasis	1.49e-05	0.000282	CbGpPWpGaD
Sulfasalazine—CHUK—Cytokine Signaling in Immune system—TYK2—psoriasis	1.47e-05	0.000279	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—SOCS1—psoriasis	1.46e-05	0.000278	CbGpPWpGaD
Sulfasalazine—IKBKB—Toll-like Receptor Signaling Pathway—IL6—psoriasis	1.46e-05	0.000277	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by PDGF—STAT3—psoriasis	1.45e-05	0.000276	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—NDUFA5—psoriasis	1.45e-05	0.000275	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by NGF—TYK2—psoriasis	1.45e-05	0.000274	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	1.44e-05	0.000274	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—ITGAL—psoriasis	1.43e-05	0.000271	CbGpPWpGaD
Sulfasalazine—PPARG—Adipogenesis—IL6—psoriasis	1.41e-05	0.000268	CbGpPWpGaD
Sulfasalazine—SLC46A1—Metabolism—APOE—psoriasis	1.41e-05	0.000268	CbGpPWpGaD
Sulfasalazine—IKBKB—Regulation of toll-like receptor signaling pathway—TNF—psoriasis	1.41e-05	0.000268	CbGpPWpGaD
Sulfasalazine—CHUK—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	1.41e-05	0.000268	CbGpPWpGaD
Sulfasalazine—TBXAS1—Metabolism—PPARG—psoriasis	1.41e-05	0.000268	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—SOCS1—psoriasis	1.41e-05	0.000267	CbGpPWpGaD
Sulfasalazine—CHUK—Toll Like Receptor 4 (TLR4) Cascade—IL6—psoriasis	1.4e-05	0.000265	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling by Interleukins—IL6—psoriasis	1.4e-05	0.000265	CbGpPWpGaD
Sulfasalazine—PPARG—Gene Expression—CARM1—psoriasis	1.39e-05	0.000265	CbGpPWpGaD
Sulfasalazine—SLC7A11—Hemostasis—VEGFA—psoriasis	1.39e-05	0.000263	CbGpPWpGaD
Sulfasalazine—IKBKB—B Cell Activation—NFKB1—psoriasis	1.39e-05	0.000263	CbGpPWpGaD
Sulfasalazine—CHUK—Cytokine Signaling in Immune system—IFNG—psoriasis	1.38e-05	0.000261	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—NDUFA5—psoriasis	1.36e-05	0.000259	CbGpPWpGaD
Sulfasalazine—PTGS1—Selenium Micronutrient Network—IL6—psoriasis	1.35e-05	0.000257	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.35e-05	0.000257	CbGpPWpGaD
Sulfasalazine—IKBKB—Activated TLR4 signalling—IL6—psoriasis	1.35e-05	0.000256	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—REL—psoriasis	1.34e-05	0.000254	CbGpPWpGaD
Sulfasalazine—IKBKB—Cytokine Signaling in Immune system—TYK2—psoriasis	1.33e-05	0.000253	CbGpPWpGaD
Sulfasalazine—PTGS2—Selenium Micronutrient Network—TNF—psoriasis	1.33e-05	0.000253	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—SOCS1—psoriasis	1.33e-05	0.000252	CbGpPWpGaD
Sulfasalazine—CHUK—NGF signalling via TRKA from the plasma membrane—STAT3—psoriasis	1.32e-05	0.00025	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling by NGF—TYK2—psoriasis	1.31e-05	0.000249	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—LEP—psoriasis	1.3e-05	0.000247	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—IFIH1—psoriasis	1.3e-05	0.000246	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—ITGAL—psoriasis	1.3e-05	0.000246	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—TYK2—psoriasis	1.29e-05	0.000245	CbGpPWpGaD
Sulfasalazine—CHUK—Integrated Breast Cancer Pathway—TP53—psoriasis	1.29e-05	0.000244	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—SOCS1—psoriasis	1.27e-05	0.000242	CbGpPWpGaD
Sulfasalazine—IKBKB—Toll Like Receptor 4 (TLR4) Cascade—IL6—psoriasis	1.27e-05	0.00024	CbGpPWpGaD
Sulfasalazine—CHUK—Regulation of toll-like receptor signaling pathway—IL6—psoriasis	1.26e-05	0.000239	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—HLA-B—psoriasis	1.25e-05	0.000237	CbGpPWpGaD
Sulfasalazine—IKBKB—Cytokine Signaling in Immune system—IFNG—psoriasis	1.25e-05	0.000237	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—CD8A—psoriasis	1.25e-05	0.000237	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by SCF-KIT—IL6—psoriasis	1.24e-05	0.000236	CbGpPWpGaD
Sulfasalazine—CHUK—Toll-Like Receptors Cascades—IL6—psoriasis	1.24e-05	0.000236	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—CYP2S1—psoriasis	1.23e-05	0.000234	CbGpPWpGaD
Sulfasalazine—SLC46A1—Metabolism—PPARG—psoriasis	1.23e-05	0.000234	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—HLA-C—psoriasis	1.23e-05	0.000233	CbGpPWpGaD
Sulfasalazine—IKBKB—MAPK Signaling Pathway—TNF—psoriasis	1.22e-05	0.000231	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—TNFAIP3—psoriasis	1.21e-05	0.00023	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—REL—psoriasis	1.21e-05	0.00023	CbGpPWpGaD
Sulfasalazine—CHUK—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	1.21e-05	0.00023	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—HLA-B—psoriasis	1.2e-05	0.000228	CbGpPWpGaD
Sulfasalazine—CHUK—Downstream signaling of activated FGFR—IL6—psoriasis	1.19e-05	0.000226	CbGpPWpGaD
Sulfasalazine—PLA2G1B—Metabolism—APOE—psoriasis	1.18e-05	0.000224	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—IFIH1—psoriasis	1.18e-05	0.000223	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by ERBB4—IL6—psoriasis	1.17e-05	0.000222	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—CD4—psoriasis	1.17e-05	0.000221	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.16e-05	0.000221	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—CYP2S1—psoriasis	1.16e-05	0.00022	CbGpPWpGaD
Sulfasalazine—CHUK—Cytokine Signaling in Immune system—NFKB1—psoriasis	1.15e-05	0.000217	CbGpPWpGaD
Sulfasalazine—IKBKB—Regulation of toll-like receptor signaling pathway—IL6—psoriasis	1.14e-05	0.000217	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—HLA-B—psoriasis	1.13e-05	0.000215	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—CD8A—psoriasis	1.13e-05	0.000214	CbGpPWpGaD
Sulfasalazine—IKBKB—Toll-Like Receptors Cascades—IL6—psoriasis	1.13e-05	0.000214	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by NGF—NFKB1—psoriasis	1.13e-05	0.000214	CbGpPWpGaD
Sulfasalazine—CHUK—Downstream signal transduction—IL6—psoriasis	1.12e-05	0.000212	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—HLA-C—psoriasis	1.12e-05	0.000212	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by FGFR—IL6—psoriasis	1.11e-05	0.000211	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—HLA-A—psoriasis	1.11e-05	0.000211	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by ERBB2—IL6—psoriasis	1.11e-05	0.00021	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—CRP—psoriasis	1.1e-05	0.000209	CbGpPWpGaD
Sulfasalazine—CHUK—DAP12 signaling—IL6—psoriasis	1.1e-05	0.000209	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—TNFAIP3—psoriasis	1.1e-05	0.000209	CbGpPWpGaD
Sulfasalazine—PPARG—Circadian rythm related genes—TP53—psoriasis	1.09e-05	0.000207	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—HLA-B—psoriasis	1.09e-05	0.000206	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—CARM1—psoriasis	1.08e-05	0.000206	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism—CAT—psoriasis	1.08e-05	0.000204	CbGpPWpGaD
Sulfasalazine—PTGS2—Selenium Micronutrient Network—IL6—psoriasis	1.08e-05	0.000204	CbGpPWpGaD
Sulfasalazine—IKBKB—MAPK Signaling Pathway—TP53—psoriasis	1.07e-05	0.000203	CbGpPWpGaD
Sulfasalazine—CHUK—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	1.07e-05	0.000202	CbGpPWpGaD
Sulfasalazine—PTGS2—Spinal Cord Injury—TNF—psoriasis	1.05e-05	0.0002	CbGpPWpGaD
Sulfasalazine—SLC7A11—Hemostasis—TP53—psoriasis	1.05e-05	0.000199	CbGpPWpGaD
Sulfasalazine—IKBKB—Cytokine Signaling in Immune system—NFKB1—psoriasis	1.04e-05	0.000197	CbGpPWpGaD
Sulfasalazine—CHUK—Fc epsilon receptor (FCERI) signaling—IL6—psoriasis	1.04e-05	0.000197	CbGpPWpGaD
Sulfasalazine—CHUK—DAP12 interactions—IL6—psoriasis	1.04e-05	0.000197	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by FGFR in disease—IL6—psoriasis	1.04e-05	0.000197	CbGpPWpGaD
Sulfasalazine—CHUK—Cytokine Signaling in Immune system—STAT3—psoriasis	1.03e-05	0.000195	CbGpPWpGaD
Sulfasalazine—PLA2G1B—Metabolism—PPARG—psoriasis	1.03e-05	0.000195	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by EGFR—IL6—psoriasis	1.03e-05	0.000195	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling by NGF—NFKB1—psoriasis	1.02e-05	0.000194	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—HLA-E—psoriasis	1.02e-05	0.000194	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by EGFR in Cancer—IL6—psoriasis	1.02e-05	0.000193	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—HLA-DRB1—psoriasis	1.02e-05	0.000193	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by PDGF—IL6—psoriasis	1.01e-05	0.000193	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by NGF—STAT3—psoriasis	1.01e-05	0.000192	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—HLA-A—psoriasis	1.01e-05	0.000191	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—NFKBIA—psoriasis	1.01e-05	0.000191	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CCL20—psoriasis	1e-05	0.00019	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—CRP—psoriasis	1e-05	0.00019	CbGpPWpGaD
Sulfasalazine—PPARG—Circadian rythm related genes—IL6—psoriasis	9.98e-06	0.000189	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—TYK2—psoriasis	9.94e-06	0.000189	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—ICAM1—psoriasis	9.74e-06	0.000185	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—NFKBIA—psoriasis	9.67e-06	0.000183	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	9.57e-06	0.000182	CbGpPWpGaD
Sulfasalazine—IKBKB—Fc epsilon receptor (FCERI) signaling—IL6—psoriasis	9.41e-06	0.000179	CbGpPWpGaD
Sulfasalazine—IKBKB—Cytokine Signaling in Immune system—STAT3—psoriasis	9.33e-06	0.000177	CbGpPWpGaD
Sulfasalazine—PTGS2—Spinal Cord Injury—TP53—psoriasis	9.29e-06	0.000176	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—HLA-E—psoriasis	9.26e-06	0.000176	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	9.21e-06	0.000175	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—HLA-DRB1—psoriasis	9.2e-06	0.000175	CbGpPWpGaD
Sulfasalazine—CHUK—NGF signalling via TRKA from the plasma membrane—IL6—psoriasis	9.19e-06	0.000174	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling by NGF—STAT3—psoriasis	9.18e-06	0.000174	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—psoriasis	9.16e-06	0.000174	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—NFKBIA—psoriasis	9.13e-06	0.000173	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CCL20—psoriasis	9.08e-06	0.000172	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—STAT3—psoriasis	9.03e-06	0.000171	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—ICAM1—psoriasis	8.83e-06	0.000168	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—NFKBIA—psoriasis	8.76e-06	0.000166	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—CARM1—psoriasis	8.54e-06	0.000162	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—SOCS1—psoriasis	8.52e-06	0.000162	CbGpPWpGaD
Sulfasalazine—PTGS2—Spinal Cord Injury—IL6—psoriasis	8.5e-06	0.000161	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism—APOE—psoriasis	8.37e-06	0.000159	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	8.36e-06	0.000159	CbGpPWpGaD
Sulfasalazine—PPARG—Gene Expression—VDR—psoriasis	8.33e-06	0.000158	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—TYK2—psoriasis	8.24e-06	0.000156	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism of lipids and lipoproteins—APOE—psoriasis	8.15e-06	0.000155	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	7.98e-06	0.000151	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—CARM1—psoriasis	7.91e-06	0.00015	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—NFKB1—psoriasis	7.75e-06	0.000147	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—SOCS1—psoriasis	7.73e-06	0.000147	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—CARM1—psoriasis	7.59e-06	0.000144	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—CD8A—psoriasis	7.56e-06	0.000143	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—TYK2—psoriasis	7.48e-06	0.000142	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—CD4—psoriasis	7.46e-06	0.000141	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism—PPARG—psoriasis	7.29e-06	0.000138	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—HLA-B—psoriasis	7.27e-06	0.000138	CbGpPWpGaD
Sulfasalazine—CHUK—Cytokine Signaling in Immune system—IL6—psoriasis	7.19e-06	0.000136	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	7.17e-06	0.000136	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—CD4—psoriasis	7.16e-06	0.000136	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	7.1e-06	0.000135	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by NGF—IL6—psoriasis	7.07e-06	0.000134	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—VEGFA—psoriasis	7.03e-06	0.000133	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—STAT3—psoriasis	6.96e-06	0.000132	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—CD8A—psoriasis	6.86e-06	0.00013	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—CD4—psoriasis	6.76e-06	0.000128	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—HLA-A—psoriasis	6.74e-06	0.000128	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—JUN—psoriasis	6.67e-06	0.000127	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—CAT—psoriasis	6.67e-06	0.000127	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—HLA-B—psoriasis	6.59e-06	0.000125	CbGpPWpGaD
Sulfasalazine—IKBKB—Cytokine Signaling in Immune system—IL6—psoriasis	6.52e-06	0.000124	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—CD4—psoriasis	6.49e-06	0.000123	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism of lipids and lipoproteins—APOE—psoriasis	6.47e-06	0.000123	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—CRP—psoriasis	6.43e-06	0.000122	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—NFKB1—psoriasis	6.42e-06	0.000122	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling by NGF—IL6—psoriasis	6.41e-06	0.000122	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	6.32e-06	0.00012	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—IL6—psoriasis	6.31e-06	0.00012	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—HLA-A—psoriasis	6.22e-06	0.000118	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—NFKB1—psoriasis	6.17e-06	0.000117	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—HLA-DRB1—psoriasis	6.16e-06	0.000117	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—HLA-A—psoriasis	6.11e-06	0.000116	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—JUN—psoriasis	6.05e-06	0.000115	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—CARM1—psoriasis	6.03e-06	0.000114	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—TNF—psoriasis	6.03e-06	0.000114	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—ICAM1—psoriasis	5.91e-06	0.000112	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—NFKBIA—psoriasis	5.86e-06	0.000111	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—CRP—psoriasis	5.83e-06	0.000111	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—NFKB1—psoriasis	5.82e-06	0.000111	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—APOE—psoriasis	5.81e-06	0.00011	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—CARM1—psoriasis	5.66e-06	0.000107	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	5.64e-06	0.000107	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—NFKB1—psoriasis	5.59e-06	0.000106	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—HLA-DRB1—psoriasis	5.58e-06	0.000106	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—SOCS1—psoriasis	5.51e-06	0.000105	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—NOS2—psoriasis	5.41e-06	0.000103	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—ICAM1—psoriasis	5.36e-06	0.000102	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—NFKBIA—psoriasis	5.32e-06	0.000101	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—CAT—psoriasis	5.25e-06	9.96e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—APOE—psoriasis	5.18e-06	9.83e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—SOCS1—psoriasis	5e-06	9.48e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—IL6—psoriasis	4.86e-06	9.23e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—CAT—psoriasis	4.86e-06	9.23e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—TYK2—psoriasis	4.8e-06	9.11e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—CAT—psoriasis	4.67e-06	8.86e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—IFNG—psoriasis	4.5e-06	8.53e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—TYK2—psoriasis	4.43e-06	8.41e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—TYK2—psoriasis	4.35e-06	8.26e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—CD4—psoriasis	4.34e-06	8.24e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—APOE—psoriasis	4.08e-06	7.74e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—IFNG—psoriasis	4.08e-06	7.74e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—APOE—psoriasis	4.07e-06	7.72e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—LEP—psoriasis	4.07e-06	7.72e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—IL6—psoriasis	4.03e-06	7.65e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—CD4—psoriasis	4.01e-06	7.61e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—CD4—psoriasis	3.94e-06	7.47e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—JUN—psoriasis	3.89e-06	7.37e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—NFKBIA—psoriasis	3.79e-06	7.19e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—APOE—psoriasis	3.78e-06	7.17e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—NFKB1—psoriasis	3.74e-06	7.1e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—CAT—psoriasis	3.71e-06	7.04e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—APOE—psoriasis	3.69e-06	7e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—LEP—psoriasis	3.69e-06	7e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—HLA-A—psoriasis	3.69e-06	6.99e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—IL6—psoriasis	3.66e-06	6.94e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—APOE—psoriasis	3.63e-06	6.89e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—PPARG—psoriasis	3.55e-06	6.74e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—JUN—psoriasis	3.52e-06	6.69e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—CAT—psoriasis	3.48e-06	6.61e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—APOE—psoriasis	3.44e-06	6.53e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—NFKBIA—psoriasis	3.44e-06	6.52e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—NFKB1—psoriasis	3.39e-06	6.44e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—STAT3—psoriasis	3.36e-06	6.38e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—PPARG—psoriasis	3.29e-06	6.24e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—NOS2—psoriasis	3.21e-06	6.08e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—PPARG—psoriasis	3.16e-06	6e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—TYK2—psoriasis	3.1e-06	5.89e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—STAT3—psoriasis	3.1e-06	5.89e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—STAT3—psoriasis	3.05e-06	5.78e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—APOE—psoriasis	2.88e-06	5.47e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—TYK2—psoriasis	2.81e-06	5.34e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—APOE—psoriasis	2.71e-06	5.14e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CXCL8—psoriasis	2.7e-06	5.13e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—TYK2—psoriasis	2.63e-06	4.98e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—JUN—psoriasis	2.51e-06	4.77e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—PPARG—psoriasis	2.51e-06	4.76e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CXCL8—psoriasis	2.45e-06	4.65e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—NFKB1—psoriasis	2.42e-06	4.59e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—CD4—psoriasis	2.37e-06	4.51e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—PPARG—psoriasis	2.36e-06	4.47e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—IL6—psoriasis	2.35e-06	4.46e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—JUN—psoriasis	2.28e-06	4.32e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—VEGFA—psoriasis	2.2e-06	4.17e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—NFKB1—psoriasis	2.19e-06	4.16e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—STAT3—psoriasis	2.17e-06	4.12e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—IL6—psoriasis	2.17e-06	4.11e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—IL6—psoriasis	2.13e-06	4.04e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—VEGFA—psoriasis	1.99e-06	3.78e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—STAT3—psoriasis	1.97e-06	3.74e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—STAT3—psoriasis	1.84e-06	3.49e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—TP53—psoriasis	1.66e-06	3.15e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—IL6—psoriasis	1.52e-06	2.88e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—TP53—psoriasis	1.5e-06	2.85e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—IL6—psoriasis	1.38e-06	2.61e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—IL6—psoriasis	1.28e-06	2.44e-05	CbGpPWpGaD
